Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Understanding cannabis use and its effects on depression and suicide risk in adolescents

Official title: Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation With Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment

Run by Massachusetts General Hospital · NCT06576076 · Data updated 2026-11-12

This study is trying to see how stopping cannabis use affects depression and suicidal thoughts in teens aged 12-18 who use cannabis daily.

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment200 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedFebruary 18, 2025
Main results expectedApril 30, 2029
Study endsApril 30, 2029
Registry record updatedMarch 3, 2026
Trial IDNCT06576076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 12-18 who use cannabis daily and show current symptoms of depression.

Probably not a fit

Patients who do not use cannabis regularly or do not exhibit depressive symptoms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the relationships between cannabis use, withdrawal, depression, and suicidal ideation in adolescents aged 12-18 years. It will recruit 200 participants who use cannabis daily and exhibit symptoms of depression. The study involves a 10-week protocol, including a 2-week baseline phase with real-time monitoring of mood and substance use, followed by an 8-week randomization phase comparing cannabis abstinence with contingency management versus non-contingent monitoring. The goal is to develop effective interventions to reduce depression and suicide risk among adolescents.

Why it matters

Potential benefit: If successful, this study could lead to tailored interventions that significantly reduce depression and suicide risk in adolescents who use cannabis.

How similar studies have gone: Other studies have shown promising results in understanding the effects of substance use on mental health, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 12-18;
* Current daily or near daily cannabis use (i.e., use ≥ 4 days per week on average; Timeline Followback);
* Score ≥ 5 on PHQ-9;
* Access to an internet-capable smartphone (iOS or Android);
* Provision of at least 1 collateral contact for risk monitoring;
* Provision of informed assent (or consent if 18 years or older) and parent/guardian consent if \<age 18;
* Greater than 50% response rate to EMA prompts during the first EMA phase;
* No immediate plan to discontinue cannabis use in the next 3 months;
* Positive toxicology result for cannabis on baseline urinalysis.

Exclusion Criteria:

* Any factor that impairs ability to comprehend and effectively participate, including acute intoxication at time of consent;
* Cannabis use \>4 times/day on average (to maximize likelihood of capturing mood and SI during non-use times);
* Inability to speak/write English fluently;
* Gross cognitive impairment, for example due to florid psychosis, intellectual disability, developmental delay, or neurodegenerative disease;
* Current epilepsy diagnosis;
* Individuals who are under the legal protection of the government or state (wards of the state);
* Response of "No" to the knowledge check question regarding EMA suicidality response time;
* Inability to wear Fitbit device.

Where it's running

  • Massachusetts General Hopsital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.